Pigazzi, M., Manara, E., Buldini, B., Beqiri, V., Bisio, V., Tregnago, C., . . . Basso, G. (2015). Minimal residual disease monitored after induction therapy by RQ-PCR can contribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1 rearrangement. Haematologica.
Čikaški stil citiranjaPigazzi, Martina, et al. "Minimal Residual Disease Monitored After Induction Therapy By RQ-PCR Can Contribute to Tailor Treatment of Patients With T(8;21) RUNX1-RUNX1T1 Rearrangement." Haematologica 2015.
MLA način citiranjaPigazzi, Martina, et al. "Minimal Residual Disease Monitored After Induction Therapy By RQ-PCR Can Contribute to Tailor Treatment of Patients With T(8;21) RUNX1-RUNX1T1 Rearrangement." Haematologica 2015.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.